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Abstract 
We present an electrode based on complementary metal oxide semiconductor 
(CMOS) technology that can be made fully biocompatible and chemically inert using 
a simple, low-cost and non-specialised process. Since these devices are based on 
ubiquitous CMOS technology, the integrated circuits can be readily developed to 
include appropriate amplifiers, filters and wireless subsystems, thus reducing the 
complexity and cost of external systems. The unprocessed CMOS aluminium 
electrodes are modified using anodisation and plating techniques which do not require 
intricate and expensive semiconductor processing equipment and can be performed on 
the bench-top as a clean-room environment is not required. The resulting transducers 
are able to detect both the fast electrical activity of neurons and the slow changes in 
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impedance of growing and dividing cells. By using standard semiconductor 
fabrication techniques and well-established technologies, the approach can form the 
basis of cell-based biosensors and transducers for high throughput drug discovery 
assays, neuroprosthetics and as a basic research tool in biosciences. The technology is 
equally applicable to other biosensors that require noble metal or nanoporous 
microelectrodes. 
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CMOS; biosensor; neuron; anodic aluminum oxide (AAO); porous anodic aluminum 
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1 Introduction 
The direct interfacing of semiconductor technology to live, excitable biological tissue 
was initially demonstrated in the late 20
th
 century (Fromherz et al., 1991) and has 
continued to be of significant interest for applications such as bidirectional 
stimulation and recording systems (Supplementary information Table S1), high 
content screening or implantable electronic devices. The electrical interface between 
biological tissue and semiconductor electronics is a vital component of a successfully-
functioning system and often takes the form of a low impedance electrode (Graham et 
al., 2011a; Hierlemann et al., 2011). The electrode area of the semiconductor die must 
be both biocompatible and chemically inert which has led to the use of existing 
manufacturing methods requiring specialist and expensive device manufacture. This 
has limited their application in key areas such as high-throughput screening and drug 
discovery.  
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This paper presents an economical, flexible and biocompatible bio-sensing device 
based on standard CMOS (complementary metal oxide semiconductor) technology in 
which aluminium electrodes are modified using simple anodisation and plating 
techniques. The modification process does not require intricate and expensive 
semiconductor post-processing equipment and can be performed with simple bench-
top equipment. A clean-room environment is not required. This new approach 
provides the basis for low-cost mass-manufacture of electrodes. We  demonstrate that 
the modified CMOS is readily configured for neuron action potential recordings and 
cell-substrate impedance systems and such an approach can be used in many other 
applications such as DNA hybridisation (electrophoresis) (Liu et al., 2006) and DNA 
sequencing (Ion Torrent Systems Inc., 2010). Individual microelectrodes are 
addressable using on-chip circuits and can meet the requirements for long-term and 
non-invasive cell culture assays and label-free high content screening. 
 
2 Materials and Methods 
2.1 CMOS device construction 
The CMOS integrated circuits (ICs) comprised of 48 electrodes for recording 
extracellular action potential activity in adult mammalian neurons and for sensing the 
electric cell-substrate impedance (ECIS) of an epithelial cell line.  
 
The CMOS ICs were fabricated by austriamicrosystems AG, Germany using 0.8μm 
technology. Thirty devices were supplied in 48-pin ceramic dual in line (DIL) 
packages with removable die-cavity lids. A further 18 bare dice were partially 
encapsulated by Quik-Pak (San Diego, U.S.) using their standard manufacturing 
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process, except that biocompatible compounds were specified, namely: Silastic 
Medical Adhesive Silicone Type A (Dow Corning, U.S.) for placement of the window 
frame and Hysol CB064 (Loctite, U.S.) for encapsulation (Graham et al., 2011b). A 
cyanoacrylate adhesive was used for a permanent bond, or the glass adhered using 
Silastic 9161 (Dow Corning, UK) so that the packages could be more easily 
disassembled, e.g. for scanning electron microscopy analysis. 
 
Glass cylinders, 10 mm tall, 13 mm internal diameter (QB Glass, UK), were adhered 
to the upper surface of the packages encircling the open die cavities so that the 48 
electrodes were exposed at the base of each chamber. These formed receptacles for 
further processing of the electrodes and subsequently functioned as cell culture 
chambers (Figure 1). 
 
Figure 1. 
 
To interface the CMOS technology directly with biological tissue, while maintaining 
biocompatibility and chemical inertness the aluminium electrodes were anodised to 
form nano-porous alumina (aluminium oxide). The nano-pores were subsequently 
infiltrated with gold and plated (Graham et al., 2009a, 2009b, 2010) with platinum 
black to reduce and optimise the electrode electrical impedance for neuronal 
recordings (Figure 2). This economic and simple CMOS modification process begins 
with anodisation of the aluminium electrodes for approximately 40 minutes in 0.4 M 
phosphoric acid, followed by 20 minutes plating of the anodised nano-porous alumina 
in 59 mM gold chloride (H.Au.Cl4.3H2O) and approximately one minute for platinum 
black deposition using chloroplatinic acid (H2PtC16.6H2O) with 264 μM Lead(II) 
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acetate trihydrate. Full details of the method were presented in Graham et al., 2010. 
The net result of this process is that the CMOS aluminium electrode, which normally 
corrodes when in contact with a saline culture medium, is converted to a chemically 
inert, low impedance electrode consisting of aluminium oxide, gold and high surface 
area platinum black. 
 
Figure 2. 
 
2.2 Cell culture 
Rat dorsal root ganglion cells were cultured as previously described (England et al., 
2001). In brief, adult (250 g) Sprague-Dawley rats were housed and killed according 
to UK Home Office regulations. The dorsal root ganglia were dissected into Ham’s 
F14 media supplemented with penicillin (100 IU.ml
-1
 Sigma, UK), streptomycin (100 
μg ml-1, Sigma) L-glutamine (2mM, Sigma) and 10% foetal calf serum (FCS, 
Invitrogen, UK). The ganglia were transferred to F14 medium containing 0.125% 
collagenase and incubated at 37
°
C in 5% CO2 95% air for 40 minutes. The cells were 
further transferred into F14 medium with added nerve growth factor (50 ng ml
-1
) and 
plated on the sterile CMOS devices which had been previously coated with poly-L-
lysine (15-30 kDa, 0.01% w/v). The devices were then kept at 37
°
C in 5% CO2 / 95% 
air for 18–24 hours.  
 
The Caco-2 human epithelial cell line was chosen for the ECIS recordings as the cells 
continually divide to produce a monolayer (Hidalgo et al., 1989). Cells were cultured 
in DMEM/F-12 media supplemented with l-glutamine (1% w/v, Sigma), FCS (10% 
w/v) and non-essential amino acids (1% w/v). Cells were grown in 50 ml flasks 
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(Nunc, UK) to 90–100% confluency at 5% CO2 and 37
°
C. The cells were dissociated 
from the flasks by 3–6 minutes trypsinsation (0.5% w/v, Worthington) after having 
been rinsed in EDTA (10 mM, Sigma, UK) and calcium and magnesium free 
phosphate buffered saline. Detached cells were spun down (5 minutes at 700 rpm), re-
suspended in fresh medium and plated onto the sterilised (ethanol 30 mins) devices. 
 
2.3 Electrophysiological recording 
To demonstrate that the simply modified CMOS can sense the fast electrical activity 
of neurons, primary cultures of rat dorsal root ganglion (DRG) cells (England et al., 
2001) were plated onto poly-lysine coated CMOS devices that were incubated for 
18 h, as described in the previous section. Recordings were undertaken at 21
°
C by 
placing the CMOS devices in a 48-pin zero insertion force (ZIF) socket connected to a 
64 channel preamplifier (PAG64, Multichannel Systems) which was housed in a 
Faraday cage. The preamplifier was connected to an MC card (Multichannel Systems) 
located in a PC (generic) running MC Rack software (v 3.1, Multichannel Systems). 
The sample rate was 25 kHz per channel and the recording bandwidth was 1 Hz to 
5 kHz. Spontaneous activity was continually recorded onto a hard disk, initially in the 
culture medium and then in a modified Kreb’s solution (mM): NaCl (130), KCl (3), 
MgCl2 (1), CaCl2 (1), HEPES (5), Glucose (11), pH adjusted to 7.4 using 2 M NaOH. 
Tetrodotoxin (100 nM, TTX, Tocris, UK), Adenosine triphosphate (100 μM, ATP, 
Sigma, UK) and KCl (12 mM) were applied via the superfusion system at 21
°
C 
flowing at 2.3 ml min
-1
.    
 
  7 
2.4 Electric cell-substrate impedance sensing (ECIS) recordings 
The ability of the CMOS device to function as an electric cell-substrate impedance 
sensor (ECIS) and monitor the real-time electrical impedance changes associated with 
cell growth and division (Hidalgo et al., 1989; Prakash & Abshire, 2008) was assessed 
using the Caco-2 cell line. 
CMOS devices were placed in an incubator (5% CO2 / 95% air, 37
°
C) mounted in a 
48-pin ZIF socket. The 48 electrodes on a CMOS device were connected together as 
the active electrode and a reference electrode (Ag/AgCl wire) was placed in the 
culture media bathing the cells. Impedance was measured using a precision 
impedance analyser (Agilent 4294A) at the frequency range 40 Hz to 1 MHz. Samples 
were taken every 15 seconds for the first 15 minutes then every 1 minute for a further 
45 minutes and finally every 60 minutes for up to 5 days. Control devices with no 
cells showed impedance changes over the same period of less than 200 Ω. 
 
2.5 Data analysis 
For the electrophysiological recordings, data stored on the hard disk were converted 
to pClamp ABF files by MCDataTool (Multichannel Systems) and spike frequency 
and fast Fourier analysis data were generated using the pClamp (v8.2, Axon 
Instruments, USA) program suite. For the ECIS experiments, the imaginary 
impedance Z″ was calculated using the equation Z″ = 1/(2πfC), where C is the 
capacitance, f the signal frequency (47.9 kHz) and Z the complex impedance. 
Statistical analysis was performed using ANOVA with p > 0.05 considered 
significant.  
 
Figure 3. 
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3 Results 
3.1 Neuronal recordings 
Figure 3 shows successful recordings of action potentials initially performed in the 
culture medium and the inset shows an individual spiking event. The spontaneous 
activity of a cell, measured over a 20 s epoch, was 14.7 ± 0.1 Hz (mean ± SEM, 
n = 20). The signal to noise ratio was approximately 5:1 and power spectral analysis 
of the noise showed no unexpected peaks (Supplementary Information Figure S2). 
 
Figure 4. 
 
On superfusion with a buffer solution the firing frequency was 17.4 ± 0.1 Hz (n = 20). 
In order to confirm that the fast spiking activity was generated by action potentials of 
neurons they were successfully blocked in a selective and reversible manner by 
100 nM tetrodotoxin, a potent selective sodium channel blocker (Figure 4). Figure 5 
shows that an increase in extracellular potassium from 3 mM to 15 mM to depolarise 
the cells (by ~40 mV, predicted from the Nernst equation) also led to a reversible and 
significant (p < 0.01) increase in neuron firing rate. Similarly, the application of 
100 μM adenosine triphosphate, an excitatory neurotransmitter, also significantly 
(p < 0.01) increased the activity of the cell.  
 
Figure 5. 
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3.2 Electric cell-substrate impedance sensing (ECIS) recordings 
Figure 6 illustrates the measured increase in electrical impedance with time as the 
cells form a monolayer over the modified electrodes, compared to CMOS devices 
under identical conditions but containing no cells. 
 
Figure 6. 
 
4 Discussion 
The neuronal recording results demonstrate that the simply-modified CMOS device is 
able to record non-invasively both the spontaneous and evoked extracellular action 
potentials of mammalian neurons over a period of hours. Therefore, the device can be 
used to monitor the excitability changes in cells in response to both physiological and 
pharmacological interventions. In view of the stability of the device (see Figure 6), 
long-term monitoring of activity is possible for many days, probably weeks, making it 
suitable for in-vitro investigations into drug dependence, complex network activity, 
neurodegereration and neuronal development.  
 
The ECIS results illustrate the flexibility of the modified CMOS technology. In this 
configuration, the electrode array can be used to study tumour growth, wound healing, 
cell migration and for understanding how cells interact with a substrate (Bionas 
GmbH, 2010). A model is presented in Wegener et al. 2000 which shows an almost 
linear relationship between capacitance and the fraction of electrode surface covered 
by cells: with 1.0 being the normalised capacitance of an uncovered electrode and 0.3 
being the normalised capacitance with cells completely covering an electrode. The 
capacitance, C, is derived simply from the impedance results using C = 1/(2πfZ″), as 
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explained in Section 2.5. Transforming the data of Figure 6 in this manner 
(Supplementary information Figure S3) shows the capacitance for a single IC with 
Caco-2 cells exhibited a reduction in normalised capacitance from 1.0 to 0.4. Using 
the linear relationship, this represents electrode coverage of 86%. It is also noted that 
the capacitance stabilised at 3 days which is probably indicative of the cells becoming 
confluent. These results are therefore in broad agreement with the model. 
Unfortunately, it was not possible to correlate electrical results with images of the 
electrode array since the epi-illuminated microscope used in this work was incapable 
of imaging the flattened monolayer (the cells appearing transparent). This ECIS 
experiment therefore demonstrates the ability of the low-cost post-processed CMOS 
IC technology to function as an impedance sensor. Furthermore, re-use of the ICs 
demonstrates the corrosion resistance of the modified electrodes and the stability of 
the IC packaging to at least 40 days. 
 
As an economic method of forming generic biocompatible CMOS electrodes, the 
process is not limited to cell-based biosensors and can be used to form transducers in 
many other types of electrochemical biosensor. Potential applications therefore 
include medical diagnosis and monitoring (e.g. wound healing), medical implants 
(e.g. glucose monitoring), environmental monitoring, detecting pathogens in food and 
water and for defence through the detection of biological agents (Velusamy et al, 
2010). 
 
Further work is in progress to demonstrate that the anodising and post-processing can 
be performed via on-chip circuits. It is intended that anodisation is performed with 
zero silicon area overhead by using only the standard electrostatic discharge (ESD) 
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protection circuits that must be present in any commercial (high yield and reliable) 
CMOS device. Additionally, the authors will assess the technology as a biosensor of 
harmful biologic agents (e.g. saxitoxin): this will evaluate open porous alumina 
electrodes and porous alumina filled with gold, but with a smooth surface more suited 
to sensing antigen binding.  
 
 
5 Conclusion 
A simple method has been established by which aluminium electrodes realised in 
standard CMOS technology can be made biocompatible and sense both the fast 
electrical activity of neurons and the slow changes in impedance of growing and 
dividing cells. Since the devices are based on ubiquitous CMOS technology the 
integrated circuits can be readily developed, with minimal additional fabrication costs, 
to include appropriate amplifiers, filters and wireless subsystems, thus reducing the 
complexity and cost of the external recording system. By using standard 
semiconductor fabrication techniques and well-established technologies, such devices 
can form the basis of a wide range of applications including single-use (disposable) 
biosensors in high throughput drug discovery assays, neuroprosthetics and as a basic 
research tool in biosciences.     
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Figures 
 
Figure 1. The CMOS device and electrode layout. The silicon dimensions are 3.1 x 3.1 mm. 
 
 
Figure 2. Scanning electron microscope (SEM) image of a single electrode with section created by 
milling with a focussed ion beam (FIB). The inner circular area is the electrode (30 µm diameter). This 
is surrounded by approximately 10 µm of aluminium which appears as an outer ‘ring’ which is 
connected to the aluminium track leading off to the left. The inset shows the porous alumina filled with 
gold. Inset scale bar 200nm. 
 
 
Figure 3. Extracellular spontaneous action potentials (spikes) (a.) recorded from a DRG sampled at 
25 kHz (bandwidth 1–5000 Hz). The frequency of the neuron activity, measured over a 20 s epoch, was 
14.7 ± 0.1 Hz (mean ± SEM, n = 20) and the signal to noise ratio was approximately 5:1. The expanded 
time axis (b.) shows an individual action potential. 
 
Figure 4. The potent and selective sodium channel blocker, tetrodotoxin, reversibly inhibits 
spontaneous action potential activity. Spike frequency plotted in 1 s epochs before, during (black bar) 
and after the application of 100 nM tetrodotoxin (TTX). The gap in the horizontal axis is 900 s. 
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Figure 5. DRG excitability can be increased by extracellular potassium and neurotransmitters. a. Mean 
(± SEM, 15 x 1 s epochs) spike frequency before (‘cont’), during (‘KCl’) an after (‘wash’) an increase 
in [K+]o (3 to 15 mM) and b. before (‘cont’), during (‘ATP’) and after (‘wash’) application of 100 μM 
adenosine triphosphate. 
  
 
Figure 6. Cell growth can be measured by impedance changes. Mean imaginary impedance, Z″ 
(measured at 47.9 kHz at 37°C) over 2.7 days. (i) 4 devices containing Caco-2 cells; (ii) 3 devices 
containing the same culture medium but no cells. Only positive error bars (SEM) are shown for clarity. 
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